258 related articles for article (PubMed ID: 15292377)
21. Adjuvant therapy in high-risk colon cancer.
Bleiberg H
Semin Oncol; 2000 Oct; 27(5 Suppl 10):48-59. PubMed ID: 11049033
[No Abstract] [Full Text] [Related]
22. [Treatment of colonic cancer and follow up].
Belmonte-Montes C; Cosme-Reyes C
Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():122-5. PubMed ID: 18277499
[No Abstract] [Full Text] [Related]
23. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
[TBL] [Abstract][Full Text] [Related]
24. [Adjuvant chemotherapy for colon cancer].
Dahl O
Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3094-6. PubMed ID: 18049502
[TBL] [Abstract][Full Text] [Related]
25. [Adjuvant therapy for colon cancer].
Fey MF
Schweiz Med Wochenschr; 2000 Nov; 130(46):1760-5. PubMed ID: 11127955
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant chemotherapy for stage II (Dukes' B) colon cancer: too early for routine use.
Wein A; Hahn EG; Merkel S; Hohenberger W
Eur J Surg Oncol; 2000 Dec; 26(8):730-2. PubMed ID: 11087635
[No Abstract] [Full Text] [Related]
27. The dilemma regarding postoperative chemotherapy in primary carcinoma of the colon.
Weiss RB; DeVita VT
Surg Gynecol Obstet; 1979 Aug; 149(2):267-71. PubMed ID: 380029
[No Abstract] [Full Text] [Related]
28. Adjuvant therapy for colon cancer--what's the FUFA?
Gupta P
Natl Med J India; 1996; 9(4):174. PubMed ID: 8772335
[No Abstract] [Full Text] [Related]
29. Adjuvant therapy for colon cancer.
Saltz LB
Surg Oncol Clin N Am; 2010 Oct; 19(4):819-27. PubMed ID: 20883956
[TBL] [Abstract][Full Text] [Related]
30. Final results of randomized trials by the National Surgical Adjuvant Study of Colorectal Cancer (NSAS-CC).
Hamaguchi T; Shirao K; Moriya Y; Yoshida S; Kodaira S; Ohashi Y;
Cancer Chemother Pharmacol; 2011 Mar; 67(3):587-96. PubMed ID: 20490797
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US.
Aballéa S; Chancellor JV; Raikou M; Drummond MF; Weinstein MC; Jourdan S; Bridgewater J
Cancer; 2007 Mar; 109(6):1082-9. PubMed ID: 17265519
[TBL] [Abstract][Full Text] [Related]
32. Oxaliplatin shows significant benefit over standard therapy in early-stage colon cancer.
Oncology (Williston Park); 2004 Sep; 18(10):1313. PubMed ID: 15526833
[No Abstract] [Full Text] [Related]
33. Adjuvant trials design in colon cancer.
Hendlisz A; Golfinopoulos V
Curr Opin Oncol; 2009 Jul; 21(4):367-8. PubMed ID: 19444100
[No Abstract] [Full Text] [Related]
34. Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.
André T; Quinaux E; Louvet C; Colin P; Gamelin E; Bouche O; Achille E; Piedbois P; Tubiana-Mathieu N; Boutan-Laroze A; Flesch M; Lledo G; Raoul Y; Debrix I; Buyse M; de Gramont A
J Clin Oncol; 2007 Aug; 25(24):3732-8. PubMed ID: 17704423
[TBL] [Abstract][Full Text] [Related]
35. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: a commentary.
Abrams J
J Clin Oncol; 2005 Dec; 23(34):8564-5. PubMed ID: 16260691
[No Abstract] [Full Text] [Related]
36. Re: Pooled analysis of fluorouracil-based adjuvant therapy of stage II and III colon cancer: who benefits and by how much?
Elsaleh H; Iacopetta B
J Clin Oncol; 2005 Jan; 23(3):653-4; author reply 654-5. PubMed ID: 15659520
[No Abstract] [Full Text] [Related]
37. Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
Chua YJ; Zalcberg JR
Expert Rev Anticancer Ther; 2008 Apr; 8(4):595-604. PubMed ID: 18402526
[TBL] [Abstract][Full Text] [Related]
38. [Multimodal treatment of colon cancer?].
Fahlke J; Schmidt C; Tautenhahn J; Hribaschek A; Stübs P; Lippert H
Zentralbl Chir; 2006 Apr; 131(2):126-33. PubMed ID: 16612779
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant portal vein cytotoxic infusion for curatively resected colon cancer--is it obsolete?
Taylor I
Eur J Surg Oncol; 2005 Feb; 31(1):1-2. PubMed ID: 15642417
[No Abstract] [Full Text] [Related]
40. Adjuvant immunotherapy for cervical cancer. Two randomized controlled studies using OK-432 or sizofiran.
Okamura K; Yajima A; Noda K
J Chemother; 1989 Jul; 1(4 Suppl):1222-4. PubMed ID: 16312843
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
